Papers

3

Total Citations

16

H-Index

2

About

Dr. Tomoaki Hakariya is a urologic surgeon and researcher whose work focuses on improving outcomes in prostate cancer surgery and advancing minimally invasive robotic techniques. His major contributions center on high-risk prostate cancer management, where his 2022 study on preoperative predictors of lymph node invasion and biochemical recurrence after robot-assisted radical prostatectomy—cited 12 times—provides critical guidance for surgical planning and risk stratification in D’Amico high-risk patients. Dr. Hakariya has also demonstrated technical innovation in rare urologic conditions, including a 2024 case report of successful robot-assisted reconstruction for retrocaval ureter, a congenital anomaly seldom treated with robotic surgery. Additionally, his 2024 report on mucinous prostate cancer recurrence in the rectal wall from needle-track seeding after transrectal biopsy highlights a rare but important complication, underscoring his attention to long-term surgical outcomes and patient safety. With a growing body of work that bridges oncologic precision and robotic surgical excellence, Dr. Hakariya’s research is valuable for clinicians and trainees seeking evidence-based strategies for complex prostate cancer cases and novel robotic reconstructions.

Research Focus

Key Achievements

2
H-Index
3
Papers
16
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Preoperative Predictors of Lymph Node Invasion and Biochemical Recurrence in High-risk Prostate Cancer
12 citations · 2022
📈 Most Prolific Year: 2024 (2 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: Nagasaki University, Japan Community Healthcare Organization

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago